WOC
EXAS

West Oak Capital’s Exact Sciences EXAS Stock Holding History

West Oak Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10
Closed -$1K – 369
2021
Q1 		$1K Hold
10
– – ﹤0.01% 319
2020
Q4 		$1K Hold
10
– – ﹤0.01% 298
2020
Q3 		$1K Hold
10
– – ﹤0.01% 274
2020
Q2 		$1K Hold
10
– – ﹤0.01% 277
2020
Q1 		$1K Buy
+10
New +$812 ﹤0.01% 264
2018
Q2 		– Sell
-400
Closed -$16.1K – 338
2018
Q1 		$16.1K Buy
+400
New +$19.5K 0.01% 248
2017
Q1 		– Sell
-40
Closed -$534 – 376
2016
Q4 		$534 Hold
40
– – ﹤0.01% 338
2016
Q3 		$743 Buy
+40
New +$705 ﹤0.01% 364

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

West Oak Capital's EXAS Position: Q2 2021 in Review

West Oak Capital sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 10 shares — an estimated $1K sold.

West Oak Capital first reported a position in EXAS in Q3 2016 and held it in 8 quarters. The position peaked at $16.1K in Q1 2018. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • West Oak Capital reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • West Oak Capital sold 10 Exact Sciences shares in Q2 2021, an estimated $1K.
  • West Oak Capital first reported a position in Exact Sciences in Q3 2016 and held it in 8 quarters.
  • West Oak Capital's Exact Sciences position peaked at $16.1K in Q1 2018.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on West Oak Capital's 13F filing for Q2 2021, filed 20 Jul 2021.